tiprankstipranks
Trending News
More News >
QuiaPEG Pharmaceuticals Holding AB (DE:99B0)
:99B0
Advertisement

QuiaPEG Pharmaceuticals Holding AB (99B0) Price & Analysis

Compare
0 Followers

99B0 Stock Chart & Stats

$0.01
>-$0.01(-9.09%)
At close: 4:00 PM EST
$0.01
>-$0.01(-9.09%)

99B0 FAQ

What was QuiaPEG Pharmaceuticals Holding AB’s price range in the past 12 months?
Currently, no data Available
What is QuiaPEG Pharmaceuticals Holding AB’s market cap?
Currently, no data Available
When is QuiaPEG Pharmaceuticals Holding AB’s upcoming earnings report date?
QuiaPEG Pharmaceuticals Holding AB’s upcoming earnings report date is Aug 27, 2026 which is in 310 days.
    How were QuiaPEG Pharmaceuticals Holding AB’s earnings last quarter?
    QuiaPEG Pharmaceuticals Holding AB released its earnings results on Aug 28, 2025. The company reported >-$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-$0.001.
      Is QuiaPEG Pharmaceuticals Holding AB overvalued?
      According to Wall Street analysts QuiaPEG Pharmaceuticals Holding AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does QuiaPEG Pharmaceuticals Holding AB pay dividends?
        QuiaPEG Pharmaceuticals Holding AB does not currently pay dividends.
        What is QuiaPEG Pharmaceuticals Holding AB’s EPS estimate?
        QuiaPEG Pharmaceuticals Holding AB’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does QuiaPEG Pharmaceuticals Holding AB have?
        Currently, no data Available
        What happened to QuiaPEG Pharmaceuticals Holding AB’s price movement after its last earnings report?
        QuiaPEG Pharmaceuticals Holding AB reported an EPS of >-$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
          Which hedge fund is a major shareholder of QuiaPEG Pharmaceuticals Holding AB?
          Currently, no hedge funds are holding shares in DE:99B0

          Company Description

          QuiaPEG Pharmaceuticals Holding AB

          QUIA PHARMA AB engages in the research, development, and commercialization of drug delivery system. Its product, Uni-Qleaver®, uses releasable pegylation technology that eliminates potential drawbacks and adjusts the drug's half-life. The company was founded by Marek Kwiatkowski and is headquartered in Uppsala, Sweden.

          QuiaPEG Pharmaceuticals Holding AB (99B0) Earnings & Revenues

          Similar Stocks
          Company
          Price & Change
          Follow
          Stayble Therapeutics AB
          LIDDS AB
          Lipigon Pharmaceuticals AB
          Modus Therapeutics Holding AB
          CombiGene AB
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis